More opportunities are yet to come for investors earning through IPO. In this episode, a company associated with the pharma industry - Bluejet Healthcare Limited is preparing to be listed in the stock market through IPO. The company has filed a draft red herring prospectus (DRHP) with market regulator SEBI.
According to the information given by the company, Kotak Mahindra Capital, ICICI Securities Limited and JP Morgan India Private Limited are the book-running lead managers. At the same time, Link Intime India Private Limited is the registrar of the offer.
According to the information, 21,683,178 equity shares will be sold under the offer for sale in the IPO. This includes the sale of shares by Akshay Bansarilal Arora up to 18,366,311, and Shiven by Akshay Arora up to 3,316,867.
Let us inform you that Blue Jet is a debt-free company as of June 30, 2022. In the last three years, the company has fulfilled orders from over 350 customers in 35 countries. Its clients include Colgate Palmolive (India) Limited, Unilever, and Prinova US LLC.